Navigation Links
Don't underestimate the power of herbal teas
Date:3/1/2011

This release is available in Spanish.

Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.

U.S. Department of Agriculture (USDA)-funded scientists in Boston, Mass., have looked into the science-based evidence of health benefits from drinking three of the most popular herbals in America. Diane McKay and Jeffrey Blumberg are at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston. Both work in the center's Antioxidants Research Laboratory, which Blumberg directs.

The Agricultural Research Service (ARS)-USDA's chief intramural scientific research agency-supports the HNRCA through an agreement. The work also was funded by Boulder, Colo.-based Celestial Seasonings, a brand of The Hain Celestial Group, Inc.

Chamomile tea has long been considered a brew that soothes. But when Blumberg and McKay reviewed scientific literature on the bioactivity of chamomile, they found no human clinical trials that examined this calming effect. They did, however, publish a review article on findings far beyond sedation, describing test-tube evidence that chamomile tea has moderate antimicrobial activity and significant antiplatelet-clumping activity.

The researchers also describe evidence of bioactivity of peppermint tea. In test tubes, peppermint has been found to have significant antimicrobial and antiviral activities, strong antioxidant and antitumor actions, and some antiallergenic potential. Based on a human clinical trial, the team also has reported that drinking hibiscus tea lowered blood pressure in a group of pre-hypertensive and mildly hypertensive adults.

McKay and Blumberg have concluded that the available research on herbal teas in general is compelling enough to suggest further clinical studies.


'/>"/>

Contact: Rosalie Marion Bliss
rosalie.bliss@ars.usda.gov
301-504-4318
United States Department of Agriculture - Research, Education and Economics
Source:Eurekalert

Related biology news :

1. Prevent periodontitis to reduce the risk of head and neck cancer
2. Periodontitis and myocardial infarction: A shared genetic predisposition
3. Study: Ecological effects of biodiversity loss underestimated
4. Texas petrochemical emissions down, but still underestimated, says study
5. Opinion polls underestimate Americans concern about the environment, Stanford study finds
6. Climate projections underestimate CO2 impact
7. Landfill cover soil methane oxidation underestimated
8. Food allergies: Overestimated and underestimated
9. Researchers develop curious snapshot of powerful retinal pigment and its partners
10. Sustainability solutions need the power of networks
11. The world can be powered by alternative energy, using todays technology, in 20-40 years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
(Date:1/18/2017)... MINNETONKA, Minn. , Jan. 18, 2017 /PRNewswire/ ... eClinical technology company that supports the entire spectrum ... 2016 has been another record-breaking year for the ... and market interest in MedNet,s eClinical products and ... to the tremendous marketplace success of ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
Breaking Biology News(10 mins):
(Date:2/15/2017)... ... February 15, 2017 , ... ... and Chief Commercial Officer with GenePeeks. Matt is a veteran life sciences ... a computational genomics company focused on identifying inherited disease risk in future generations. ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. („TRIANNI") ... Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung der ... führenden Plattform für die Entdeckung monoklonaler Antikörper. ... neuartiges chimäres Gensegmentdesign aus, das Janssen den ... Antikörpern bietet und das für die schelle Isolierung ...
(Date:2/15/2017)... 15, 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the fourth quarter and full year ended December ... year for Vanda as we continued to demonstrate ... long-term exclusivity for Fanapt," said Mihael H. Polymeropoulos, ... emerging pipeline with important 2017 milestones underscores Vanda,s ...
(Date:2/15/2017)... , Feb. 15, 2017 Windtree Therapeutics, ... focused on developing aerosolized KL4 surfactant therapies for respiratory ... a slide presentation) at 8:00 AM EST on Thursday, ... phase 2 clinical program, the recently announced closing of ... development activities. To participate in the live ...
Breaking Biology Technology: